UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000043098
Receipt number R000049198
Scientific Title Study on Treatment of ulcerative colitis with infliximab originator and bio- Similar Targeting remission
Date of disclosure of the study information 2021/01/22
Last modified on 2023/07/26 15:30:54

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Study on Treatment of ulcerative colitis with infliximab originator and bio- Similar Targeting remission

Acronym

TRUST study

Scientific Title

Study on Treatment of ulcerative colitis with infliximab originator and bio- Similar Targeting remission

Scientific Title:Acronym

TRUST study

Region

Japan


Condition

Condition

ulcerative colitis

Classification by specialty

Gastroenterology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Prospectively observe the short-term and long-term efficacy and safety of Infliximab, Biosimilar(BS)1 and BS2 in patients with ulcerative colitis who received each antibody, and analyze factors that influence their effectiveness.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Remission rate 30 weeks after the start of administration in the IFX / BS1 / BS2 groups

Key secondary outcomes

1) Remission rate, treatment continuation rate, surgery rate after 2 weeks, 6 weeks, 14 weeks, 22 weeks and 30 weeks
2) Cumulative remission maintenance rate, treatment continuation rate, surgery rate (Kaplanmeier method)
3) Calculation of cross-reactivity of anti-drug antibody against IFX / BS1 / BS2 to other preparations
4) Incidence of adverse events and their contents, presence or absence of abnormal laboratory test values, etc.


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

16 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1. Age is 16 years or older at the time of obtaining informed consent
2. Partial Mayo (pMayo) score of 3 points or more before IFX / BS1 / BS2 administration
3. After receiving sufficient explanation for participating in this research, the informed consent of the research subject himself / herself has been obtained after sufficient understanding.

Key exclusion criteria

1. Patients for whom a definitive diagnosis of ulcerative colitis has not been obtained
2. Proctitis type patients
3. Patients who have been administered either IFX / BS1 / BS2 in the past
(However, cases in which treatment was discontinued after achieving remission by IFX / BS1 / BS2 treatment are excluded only when the same preparation is restarted due to relapse)
4. Patients who have been treated with adalimumab or golimumab in the past and have been primarily ineffective
5. Patients with a history of colectomy
6. Patients with or have a history of malignant disease
7. Patients with serious infectious diseases
8. Others who are judged by the principal investigator to be inappropriate as research subjects

Target sample size

150


Research contact person

Name of lead principal investigator

1st name Takehiko
Middle name
Last name Katsurada

Organization

Hokkaido University Hospital

Division name

Division of endoscopy

Zip code

060-8648

Address

Kita 14, Nishi 5, Kita-ku, Sapporo, Japan

TEL

011-706-7715

Email

tkatsu@med.hokudai.ac.jp


Public contact

Name of contact person

1st name Takehiko
Middle name
Last name Katsurada

Organization

Hokkaido University Hospital

Division name

Division of endoscopy

Zip code

060-8648

Address

Kita 14, Nishi 5, Kita-ku, Sapporo, Japan

TEL

011-706-7715

Homepage URL


Email

tkatsu@med.hokudai.ac.jp


Sponsor or person

Institute

Sapporo Medical University

Institute

Department

Personal name



Funding Source

Organization

Self funding

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Hokkaido University Hospital Division of Clinical Research Administration

Address

Kita 14, Nishi 5, Kita-ku, Sapporo, Hokkaido, 060-8648, Japan

Tel

011-706-7636

Email

crjimu@huhp.hokudai.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2021 Year 01 Month 22 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2020 Year 06 Month 24 Day

Date of IRB

2019 Year 11 Month 08 Day

Anticipated trial start date

2020 Year 06 Month 29 Day

Last follow-up date

2030 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Prospective observational study (no invasive)


Management information

Registered date

2021 Year 01 Month 22 Day

Last modified on

2023 Year 07 Month 26 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000049198


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name